360
Background:
Cancer survivorship care for women remains fragmented with unmet needs particularly for menopause care and sexual health, which impact quality of life and medication adherence. This is particularly apparent when therapeutic options are constrained by avoidance of systemic hormonal medications. T...
Melissa Matson, Jordan T. Lee, Devin Johnson et al.· JCO Oncology Practice· 0 citations
158
Background:
Accurate estimation of county-level lung cancer screening prevalence at geographic levels smaller than states is limited by the lack of individual-level smoking history data to assess eligibility, with existing publicly available smoking data lacking geographic and/or demographic granularity. We...
J. Lund, Bradford E. Jackson, Christopher Baggett et al.· JCO Oncology Practice· 0 citations
BACKGROUND
Patients with endocrine-resistant hormone receptor-positive (HR+), HER2-negative metastatic breast cancer (MBC) have limited effective treatment options. Heat shock protein 90 (HSP90) regulates estrogen receptor stability and function; its inhibition has been proposed as a strategy to overcome endocrine resi...
A. Grinshpun, A. Waks, Jing-Xin Fu et al.· The Oncologist· 0 citations
An electronic health record-based prognostic model is developed to identify patients with metastatic breast cancer at high risk of near-term death and can predict risk of death within 30 and 90 days for patients with MBC.
E. Ray, Xin-Yi Zhang, Lisette N. Dunham et al.· JCO Oncology Practice· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.
